WORLD EMERGENCY MEDICINE SOCIETIES & RELATED

Search

Content:

Tuesday, February 9, 2021

Anticoagulation in Covid-19 (2021 ASH)

American Society of Hematology. February 08, 2021 - By Cuker A et al.
The American Society of Hematology (ASH) guideline panel suggests using prophylactic-intensity over intermediate-intensity or therapeutic-intensity anticoagulation for patients with coronavirus disease 2019 (COVID-19)–related critical illness who do not have suspected or confirmed venous thromboembolism (VTE) (conditional recommendation based on very low certainty in the evidence about effects
The ASH guideline panel suggests using prophylactic-intensity over intermediate-intensity or therapeutic-intensity anticoagulation for patients with COVID-19–related acute illness who do not have suspected or confirmed VTE (conditional recommendation based on very low certainty in the evidence about effects